264 related articles for article (PubMed ID: 26447758)
1. Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.
Guan SS; Cheng CC; Ho AS; Wang CC; Luo TY; Liao TZ; Chang J; Wu CT; Liu SH
Oncotarget; 2015 Nov; 6(34):36139-55. PubMed ID: 26447758
[TBL] [Abstract][Full Text] [Related]
2. A novel
Guan SS; Wu CT; Liao TZ; Lin KL; Peng CL; Shih YH; Weng MF; Chen CT; Yeh CH; Wang YC; Liu SH
Eur J Pharm Biopharm; 2021 Nov; 168():38-52. PubMed ID: 34450241
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
Schweiger T; Kollmann D; Nikolowsky C; Traxler D; Guenova E; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Eur J Cardiothorac Surg; 2014 Jul; 46(1):92-9. PubMed ID: 24321995
[TBL] [Abstract][Full Text] [Related]
5. Development and biological evaluation of ⁹⁹mTc-sulfonamide derivatives for in vivo visualization of CA IX as surrogate tumor hypoxia markers.
Akurathi V; Dubois L; Celen S; Lieuwes NG; Chitneni SK; Cleynhens BJ; Innocenti A; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Eur J Med Chem; 2014 Jan; 71():374-84. PubMed ID: 24378650
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
[TBL] [Abstract][Full Text] [Related]
7. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
Bao B; Groves K; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Rajopadhye M; Peterson JD
PLoS One; 2012; 7(11):e50860. PubMed ID: 23226406
[TBL] [Abstract][Full Text] [Related]
9. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
Parks SK; Cormerais Y; Durivault J; Pouyssegur J
Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.
Akurathi V; Dubois L; Lieuwes NG; Chitneni SK; Cleynhens BJ; Vullo D; Supuran CT; Verbruggen AM; Lambin P; Bormans GM
Nucl Med Biol; 2010 Jul; 37(5):557-64. PubMed ID: 20610160
[TBL] [Abstract][Full Text] [Related]
12. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.
Lau J; Liu Z; Lin KS; Pan J; Zhang Z; Vullo D; Supuran CT; Perrin DM; Bénard F
J Nucl Med; 2015 Sep; 56(9):1434-40. PubMed ID: 26205302
[TBL] [Abstract][Full Text] [Related]
13. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model.
Dubois L; Lieuwes NG; Maresca A; Thiry A; Supuran CT; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2009 Sep; 92(3):423-8. PubMed ID: 19616332
[TBL] [Abstract][Full Text] [Related]
14. CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer.
Wang G; Cheng Z; Liu F; Zhang H; Li J; Li F
Cell Signal; 2015 Jul; 27(7):1369-79. PubMed ID: 25843777
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors.
Groves K; Bao B; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Peterson JD; Rajopadhye M
Bioorg Med Chem Lett; 2012 Jan; 22(1):653-7. PubMed ID: 22079760
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ
Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX.
Iikuni S; Okada Y; Shimizu Y; Watanabe H; Ono M
Bioorg Med Chem Lett; 2020 Jul; 30(14):127255. PubMed ID: 32527556
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]